LCL
Showing 1 - 25 of 93
Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston
Completed
- Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 27, 2022
Lateral Canthal Lines, LCL, Crow's Feet Trial in United States (Vehicle, botulinum toxin, Type A)
Active, not recruiting
- Lateral Canthal Lines, LCL
- Crow's Feet
- Vehicle
- botulinum toxin, Type A
-
Aventura, Florida
- +8 more
May 6, 2022
Lateral Canthal Lines, Crow's Feet Trial in United States (botulinum toxin, Type A, Vehicle)
Completed
- Lateral Canthal Lines
- Crow's Feet
- botulinum toxin, Type A
- Vehicle
-
Miami, Florida
- +4 more
Jul 27, 2022
Lateral Canthal Lines, Crow's Feet Trial in United States (Vehicle, botulinum toxin, Type A)
Completed
- Lateral Canthal Lines
- Crow's Feet
- Vehicle
- botulinum toxin, Type A
-
Miami, Florida
- +5 more
Apr 19, 2022
Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Trial in
Completed
- Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
- PDR001
- +5 more
-
Santa Monica, California
- +24 more
Mar 11, 2022
Glabellar Frown Lines (GL), Lateral Canthal Lines (LCL) Trial in Canada, United States (botulinum toxin neuromodulator, Placebo)
Completed
- Glabellar Frown Lines (GL)
- Lateral Canthal Lines (LCL)
- botulinum toxin neuromodulator
- Placebo
-
Encino, California
- +11 more
Aug 24, 2022
BIOSUREā¢ RG Knee Safety & Performance Study
Completed
- ACL Repair
- +9 more
-
Rockford, Illinois
- +2 more
Jul 7, 2021
Glabellar Lines, Lateral Canthal Lines Trial in Worldwide (MT10109L, Placebo)
Completed
- Glabellar Lines
- Lateral Canthal Lines
- MT10109L
- Placebo
-
Glendale, Arizona
- +20 more
Sep 2, 2022
Moderate to Severe Upper Facial Lines Trial in Berlin (IPN10200, IPN10200 Placebo, Dysport)
Recruiting
- Moderate to Severe Upper Facial Lines
- IPN10200
- +2 more
-
Antibes, France
- +8 more
Jan 26, 2023
Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines) Trial in
Completed
- Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)
- NT 201
- Placebo
-
Bad Soden, Germany
- +11 more
Jul 25, 2022
Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines) Trial in
Completed
- Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)
- NT 201
- Placebo
-
Encino, California
- +11 more
May 23, 2022
Lateral Canthal Lines Trial in Canada, United States (botulinum toxin, Placebo)
Completed
- Lateral Canthal Lines
- botulinum toxin
- Placebo
-
Manhattan Beach, California
- +9 more
Aug 24, 2022
Ezetimibe-Rosuvastatin Evaluation Study
Not yet recruiting
- Hypercholesterolemia
- +2 more
-
Athens, GreeceAthens University Hospital
May 19, 2022
Lymphoma, Large B-Cell, Diffuse Trial in Madison (R-CHOP+GM-CSF)
Completed
- Lymphoma, Large B-Cell, Diffuse
-
Madison, WisconsinUniversity Of Wisconsin
Dec 12, 2019
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Scottsdale, Jacksonville, Rochester (Cyclophosphamide,
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Cyclophosphamide
- +4 more
-
Scottsdale, Arizona
- +2 more
Aug 29, 2019
Multiligament Knee Injuries Trial (OrthoPure XT)
Not yet recruiting
- Multiligament Knee Injuries
- OrthoPure XT
- (no location specified)
Jan 9, 2023
Lateral Canthal Lines, Glabellar Lines Trial in Canada, Germany, United States (MT10109L, Placebo)
Completed
- Lateral Canthal Lines, Glabellar Lines
- MT10109L
- Placebo
-
Scottsdale, Arizona
- +18 more
Mar 3, 2021
Glabellar Lines, Lateral Canthal Lines Trial in Puerto Rico, United States (botulinum toxin neuromodulator)
Completed
- Glabellar Lines
- Lateral Canthal Lines
- botulinum toxin neuromodulator
-
Birmingham, Alabama
- +29 more
May 26, 2021
Lateral Canthal Lines Trial in United States (DaxibotulinumtoxinA for injection)
Completed
- Lateral Canthal Lines
- DaxibotulinumtoxinA for injection
-
Sacramento, California
- +3 more
Feb 16, 2021
Lateral Canthal Lines, Crow's Feet Trial in Cary (botulinum toxin, Type A, Vehicle)
Completed
- Lateral Canthal Lines
- Crow's Feet
- botulinum toxin, Type A
- Vehicle
-
Cary, North CarolinaCary Skin Care
Apr 19, 2022
Crow's Feet Trial in Seoul (DKB-119)
Active, not recruiting
- Crow's Feet
- DKB-119
-
Seoul, Korea, Republic ofChungang-University Hospital
Aug 28, 2023